Skip to search formSkip to main contentSkip to account menu

CEP 7 Probe

Known as: 7p11.1-q11.1, CEP7, Chromosome 7 Centromere Probe 
A set of DNA probes designed for use in FISH. This probe set amplifies a region of chromosome 7 spanning from 7p11.1 to 7q11.1 which includes the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Multiple independent methods fail to confirm MET amplification rate reported in literature for metastatic colorectal cancer (mCRC).
572 Background: MET inhibition is emerging as a potent therapeutic strategy and MET gene amplification has shown predictive… 
2015
2015
Method and related kit for detecting c-MET/CEP7 gene status based on rare cells
The invention relates to a method and a related kit for detecting c-MET/CEP7 gene status based on rare cells, wherein the method… 
2014
2014
Amplification of the EGFR / CEP 7 Gene Using FISH on a Paraffin-Embedded Section April 2013
  • 2014
  • Corpus ID: 15386698
While CADTH has taken care in the translation of the document to ensure it accurately represents the content of the original… 
2013
2013
Behavior of circulating epithelial tumor cells (CETC) and FISH (fluorescence in situ hybridisation) of epidermal growth factor receptor (EGFR)-gene amplification in lung cancer patients during the…
Introduction: Monitoring the response of CETC to therapy in lung cancer allows early detection of patients at risk of progression… 
2013
2013
Abstract A32: Colorectal cancer stroma: Tumor cells in disguise
Background: Epithelial-to-mesenchymal transition (EMT) is thought to mediate cancer cell dissemination and metastasis. However… 
2012
2012
Abstract 5548: High copy number of theMET genepredicts resistance to EGFR-TKI in non-small cell lung cancer patients.
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Background Non-small cell lung cancer (NSCLC… 
2010
2010
Tumor molecular correlates of unresectable, locally advanced head and neck squamous cell carcinoma (SCCHN) response to concurrent radiation (RT), cisplatin (DDP), and cetuximab (C225) in a phase II…
5537 Background: The molecular characteristics of SCCHN associated with response to C225 alone or in combination with RT and DDP… 
2010
2010
Phase II trial of preoperative vinorelbine/trastuzumab (VH) or docetaxel/carboplatin/trastuzumab (TCH) in HER2-positive breast cancer with analysis of resistance mechanisms.
549 Background: Alterations in the PI3-Kinase (PI3K) pathway, loss of HER2 amplification, and activation of growth factor… 
2008
2008
Molecular characterization of chromosome 7 in AML and MDS patients
Myelodysplastic syndromes (MDS) share many features with acute myeloid leukemias (AML) and in fact 20 - 40% of the patients… 
2008
2008
Fluorescence In situ Hybridization Subgroup Analysis ofTRIBUTE , a Phase III Trial of Erlotinib Plus Carboplatin and Paclitaxel in Non ^ Small Cell Lung Cancer
Purpose: TRIBUTE was a phase III trial evaluating the addition of erlotinib to carboplatin and paclitaxel as a first-line… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)